ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Gene replacement therapy that works in dogs to be tested in children – KIRO Seattle

Continue reading

2017-05-19 Michael Zand NEWS

Gene replacement therapy that works in dogs to be tested in children – KIRO Seattle


KIRO Seattle

Gene replacement therapy that works in dogs to be tested in children
KIRO Seattle
In video obtained by KIRO 7, dogs that were destined to die show no signs of the disease after a single infusion of gene-replacement therapy. The disease is so deadly in children, 50-percent of them die before their second birthday. “This is a huge deal.

Continue reading

2017-05-19 Michael Zand NEWS

How neural stem cells can become blood vessels – Science Daily


KIRO Seattle

Gene replacement therapy that works in dogs to be tested in children
KIRO Seattle
In video obtained by KIRO 7, dogs that were destined to die show no signs of the disease after a single infusion of gene-replacement therapy. The disease is so deadly in children, 50-percent of them die before their second birthday. “This is a huge deal.

Continue reading

2017-05-18 Michael Zand NEWS

How neural stem cells can become blood vessels – Science Daily

How neural stem cells can become blood vessels
Science Daily
In this sense, “we describe that the adult stem cells from the carotid body taken from the neural crest (CBSCs) are capable of experiencing endothelial differentiation, as well as their already described role in neurogenesis, contributing to both …

Continue reading

2017-05-18 Michael Zand NEWS

Stem Pharm Aims to Add to Madison’s Stem Cell Past with Biomaterials – Xconomy

How neural stem cells can become blood vessels
Science Daily
In this sense, “we describe that the adult stem cells from the carotid body taken from the neural crest (CBSCs) are capable of experiencing endothelial differentiation, as well as their already described role in neurogenesis, contributing to both …

Continue reading

2017-05-18 Michael Zand NEWS

Stem Pharm Aims to Add to Madison’s Stem Cell Past with Biomaterials – Xconomy


Scientific American

Stem Pharm Aims to Add to Madison’s Stem Cell Past with Biomaterials
Xconomy
In the years since researchers at the University of Wisconsin-Madison derived the first human embryonic stem cell line, in 1998, numerous stem cell-focused businesses have popped up in the area. Each one has its own unique concentration, but the …
Lab-Grown Blood Stem Cells Produced at LastScientific American
Self-renewing hematopoietic stem cells createdScience Daily
Scientists get closer to making personalized blood cells by using patients’ own stem cellsLos Angeles Times
Phys.Org –The Scientist
all 34 news articles »
Continue reading

2017-05-18 Michael Zand NEWS

Anti-CD19 CAR-T cell therapy with defined T-cell subsets for ibrutinib-refractory CLL – presentation at iwCLL 2017 – Lymphoma Hub


Scientific American

Stem Pharm Aims to Add to Madison’s Stem Cell Past with Biomaterials
Xconomy
In the years since researchers at the University of Wisconsin-Madison derived the first human embryonic stem cell line, in 1998, numerous stem cell-focused businesses have popped up in the area. Each one has its own unique concentration, but the …
Lab-Grown Blood Stem Cells Produced at LastScientific American
Self-renewing hematopoietic stem cells createdScience Daily
Scientists get closer to making personalized blood cells by using patients’ own stem cellsLos Angeles Times
Phys.Org –The Scientist
all 34 news articles »
Continue reading

2017-05-18 Michael Zand NEWS

MultiVir Reports Gene Therapy Enhancement of Cancer Immunotherapy – PR Newswire (press release)

MultiVir Reports Gene Therapy Enhancement of Cancer ImmunotherapyPR Newswire (press release)WASHINGTON, May 18, 2017 /PRNewswire/ — MultiVir Inc., a leading developer of gene therapies for cancer treatment, presented new data at the Annual Meeting of … Continue reading

2017-05-18 Michael Zand NEWS
  • 1
  • …
  • 1,708
  • 1,709
  • 1,710
  • 1,711
  • 1,712
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Lymphoma Hub

Anti-CD19 CAR–T cell therapy with defined T-cell subsets for ibrutinib-refractory CLL – presentation at iwCLL 2017
Lymphoma Hub
Maloney began by explaining that CAR–T cells produced from distinct T-cell subsets differ in potency. NSG mice bearing Raji tumors (0.5×106 tumor cell inoculation; day 0) were treated with human CAR–T cells manufactured from distinct T-cell subsets (on …